Conversation with The Cancer LetterFree Prasad: FDA has confused merely approving drugs with making the world a better place June 22, 2018Vol.44 No.25By Paul Goldberg
Free Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine June 22, 2018Vol.44 No.25By Paul Goldberg
Letter To The Editor MammaPrint has remained consistent and credible since introduction more than a decade ago June 15, 2018Vol.44 No.24By William Audeh
Change in culture needed to prevent sexual harassment at academic institutions, NASEM says June 15, 2018Vol.44 No.24By Matthew Bin Han Ong
Guest Editorial The Trump administration “American Patients First” plan to reduce drug prices—Are American cancer patients first? June 15, 2018Vol.44 No.24By Hagop M. Kantarjian and Mary Alma Welch
FreeTrials & Tribulations Searching for Breast Cancer’s “Extreme Survivors” June 08, 2018Vol.44 No.23By Mark Burkard
Free Sharpless: NCI adds $10 million for NCTN and NCORP trials June 08, 2018Vol.44 No.23By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Abrams: Only about 20-30 percent of the group might benefit from chemotherapy June 08, 2018Vol.44 No.23By Paul Goldberg
Free Big takeaway from ASCO:70 percent of women with early breast cancer don't benefit from adjuvant chemotherapy June 08, 2018Vol.44 No.23By Paul Goldberg
